Skip to main navigation
  • R&D
    • Research
    • Novel Proprietary Systems
    • Science Communications
  • Therapeutic Approach
  • About Us
  • Careers
  • Investors
  • LinkedIn
  • Terms of Service
  • Privacy Policy
  • Careers
Contact

info@metagenomi.co

 

© 2026 Metagenomi Therapeutics, Inc.

HERO

SEC Filing Details

Investor Menu

Investor Relations

  • Most Recent Information
  • News & Events
    • News Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • Annual Reports
    • SEC Filings
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Document Details

Form
10-Q
Filing Date
Nov 12, 2025
Document Date
Sep 30, 2025
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Metagenomi Therapeutics, Inc.
Issuer
METAGENOMI THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Headquarters
5959 Horton St, Floor 7
Emeryville, California 94608

Other Locations

1545 Park Avenue
Emeryville, California 94608

1485 Park Avenue
Emeryville, California 94608

Contact

info@metagenomi.co

 
  • LinkedIn
  • Terms of Service
  • Privacy Policy
  • Careers

© 2026 Metagenomi Therapeutics, Inc.

© 2026 Metagenomi Therapeutics, Inc.